🇮🇳IN
Sign In
AN

ANONDITA

NSE

ANONDITA MEDICARE LIMITED

₹991.45

+11.00(+1.12%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

ANONDITA financial summary

For Mar 2026, ANONDITA MEDICARE LIMITED reported revenue of ₹112 crore, which grew 83.6% from the previous year. Net profit was ₹27 crore, which grew 145.5% year on year, on an operating margin of 35%. Earnings per share came in at ₹14.12. Annual results are available for 2 financial years, from Mar 2025 to Mar 2026.

Revenue₹112 crore
Net profit₹27 crore
Operating margin35%
EPS₹14.12

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer